Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In September 2024, Hikma Pharmaceuticals PLC finalized the acquisition of Xellia Pharmaceuticals US finished dosage form business with a deal including a facility in Ohio, Sales and marketing capabilities, and an R&D center in Croatia, aiming to strengthen the commercial portfolio and production supplements
The swift increase in prevalence has sparked a surge of research in recent years
Davies M et al
GLP-1 Medications and Gallbladder Risk in Patients Who Still Have One For patients with an intact gallbladder, some observational data suggests that rapid weight loss from GLP-1 therapy may increase the risk of gallstone formation, particularly during the initial weeks of treatment
